Myeloid cell nuclear differentiation antigen (MNDA) has recently been described as a sensitive (although not completely specific) marker of nodal and splenic marginal zone lymphomas, that might be useful both in primary sites and in the bone marrow [8]. Here, MNDA is linked to splenic marginal zone lymphoma.